Press Review

Key Takeaways Top story: AI systems now detect ADHD with over 90% accuracy using visual analysis, marking a significant advance in early identification. Girls’ ADHD symptoms are frequently overlooked in routine screenings, often leading to delayed support. Daily screen time…

Key Takeaways A new study reports an AI model now detects adult ADHD with 90% accuracy using visual processing. The Press Review for 2 November 2025 highlights diagnostic gaps for women and introduces new practical tools supporting neurodivergent professionals. Top…

Key Takeaways On 1 November 2025, ADHD news and developments focus on CTx-1301, a once-daily ADHD medication showing strong results in Phase 3 trials. New Zealand eases access to diagnosis, and new studies highlight gender gaps and trends in treatment….

Key Takeaways A new hybrid parent training program integrates proven ADHD strategies with a dedicated smartphone app, supporting families navigating ADHD neurodivergence. Today’s review highlights new data on preschool ADHD medication use, AI-driven executive function tools, and entrepreneurial approaches to…

Key Takeaways On 30 October 2025, today’s Press Review highlights a significant advance in ADHD news and developments with the CTx-1301 Phase 3 trial indicating the potential for once-daily dosing in children. Top story: The CTx-1301 Phase 3 trial reports…

Key Takeaways Top story: New Zealand enables GPs and nurse practitioners to diagnose ADHD, promising faster, more flexible access. Study finds women with ADHD often face longer diagnostic delays and more severe outcomes. AI-powered assistant launched to support neurodivergent professionals…

Key Takeaways On 28 October 2025, the ADHD news review highlights new research revealing that insomnia has a major impact on life quality for adults with ADHD. Insomnia significantly reduces life quality in adults with ADHD, according to new research….

Key Takeaways Top story: Women with ADHD often receive diagnoses much later than men, leading to less effective interventions and increased challenges. New research questions how auditory noise impacts cognitive performance in people with ADHD neurodivergence. AI-driven productivity tools are…

Key Takeaways A major Swedish study leads today’s ADHD news and research, finding that medication is linked to lower impulsive behavior and crime rates in adults with ADHD. Top story: Swedish research links ADHD medication to significant reductions in impulsivity…

Key Takeaways Top story: AI productivity tools are now tailored for neurodivergent professionals, offering new pathways for workplace inclusion and efficiency. Growing ADHD awareness and tools are prompting organizations to rethink the management of adult ADHD diagnoses. Researchers have identified…